BRAX — Braxia Scientific Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Braxia Scientific, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2019 September 30th | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.856 | 11.1 | 8.68 | 1.46 |
Net Total Receivables | — | 0.113 | 0.811 | 0.409 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 1.04 | 11.4 | 9.66 | 2.16 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | — | 0.05 | 0.168 | 0.82 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Total Assets | 1.16 | 18.5 | 11.6 | 3.88 |
Accounts Payable | ||||
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.053 | 2.55 | 2.54 | 2.15 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.053 | 2.6 | 2.67 | 2.28 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 1.11 | 15.9 | 8.96 | 1.6 |
Total Liabilities & Shareholders' Equity | 1.16 | 18.5 | 11.6 | 3.88 |
Total Common Shares Outstanding |